Advertisement

Intra-Arterial Cisplatin Chemotherapy for Osteogenic Sarcoma

  • Soo-Yong Lee
  • Chin Youb Chung
  • Goo Hyun Baek
  • Hong Sik Byun
Conference paper

Abstract

The classical method for treating osteogenic sarcoma had been amputation followed by chemotherapy for about 1 year. Recently, preoperative chemotherapy has been tried in many cancer centers [1–3], with the resultant benefits of controlling micrometastasis, permitting the analysis of the response of the tumor to chemotherapy, and providing a better chance to save the endangered limb by reducing and consolidating the tumor volume [4]. Intra-arterial preoperative chemotherapy has been shown to control local lesions very effectively [3].

Keywords

Preoperative Chemotherapy Limb Salvage Pediatric Osteosarcoma Korea Cancer Center Hospital Glutamate Oxalate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Eilber F, Grant T, Morton D (1978) Adjuvant therapy for osteosarcoma: Preoperative and postoperative treatment. Cancer Treat Rep 62: 213–216PubMedGoogle Scholar
  2. 2.
    Rosen G, Caparros B, Huvos A, Kosloff C, Nirrenberg A, Cacavio A, Marcove R, Lane J, Metha B, Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma. (Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy). Cancer 49: 1221–1230PubMedCrossRefGoogle Scholar
  3. 3.
    Stine KC, Hockenberry MJ, Harrelson I, Miner D, Falletta JM (1989) Systemic doxorubicin and intraarterial cisplatin preoperative chemotherapy plus postoperative adjuvant chemotherapy in patients with osteosarcoma. Cancer 63: 848–853PubMedCrossRefGoogle Scholar
  4. 4.
    Simon MA, Aschliman M, Thomas N, Mankin HJ (1986) Limb salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone and Joint Surg [Am] 68: 1331–1337Google Scholar
  5. 5.
    Ochs J, Freeman A, Douglass HJ, Hingby D, Mindell E, Sinks L (1978) Cisdiamminedichloroplatinum (II) in advanced osteogenic sarcoma. Cancer Treat Rep 62: 239–245PubMedGoogle Scholar
  6. 6.
    Jaffe N, Knapp J, Chuang V, Wallace C, Ayala A, Murray J, Cangir A, Wang A, Benzamin R (1983) Osteosarcoma: Intraarterial treatment of the primary tumor with cis-Diamminedichloroplatinum II (CDP): Angiographic, pathologic and pharmacologic studies. Cancer 51: 402–407PubMedCrossRefGoogle Scholar
  7. 7.
    Enneking WF (1986) A system of staging musculoskeletal neoplasms. Clin Orthop 204: 9–24PubMedGoogle Scholar
  8. 8.
    Huvos AG, Rosen G, Marcove CR (1977) Primary osteogenic sarcoma: Pathologic aspects in 20 patients after treatment with chemotherapy, en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med 101 (1): 14–18PubMedGoogle Scholar
  9. 9.
    Kaplan EL, Meier R (1958) Nonparametric estimation from incomplete observation. J Am Stat Assoc 53: 457–481CrossRefGoogle Scholar
  10. 10.
    Benjamin R, Chawla S, Carrasco C (1988) Arterial infusion in the treatment of osteosarcoma. In: Ryan J, Baker L (eds) recent concepts in sarcoma treatment. Kluwer, Dordrecht, pp 269–274CrossRefGoogle Scholar
  11. 11.
    Jaffe N (1989) Chemotherapy for malignant bone tumors. Orthop Clin North America 20 (3): 487–503Google Scholar
  12. 12.
    Jaffe N, Prudich J, Knapp J, Wang Y, Bowman R, Cangir A, Ayala A, Chuang V, Wallace S (1983) Treatment of primary osteosarcoma with intraarterial and intravenous high dose methotrexate. J Clin Oncol 1 (7): 428–431PubMedGoogle Scholar
  13. 13.
    Jaffe N, Raymond A, Ayala A, Carrasco C, Wallace S, Robertson R, Griffiths M, Wang Y (1989) Effect of cumulative courses of intraarterial cisDiamminedichloroplatinum-II on the primary tumor in pediatric osteosarcoma. Cancer 63: 63–67PubMedCrossRefGoogle Scholar
  14. 14.
    Jaffe N, Spears R, Eftekhari F, Robertson R, Cangir A, Takaue Y, Carrasco C (1987) Pathologic fracture in osteosarcoma: Impact of chemotherapy on primary tumor and survival. Cancer 59: 27–35CrossRefGoogle Scholar
  15. 15.
    Carter SK (1980) The dilemma of adjuvant chemotherapy for osteogenic sarcoma. Cancer Clin Trials 3: 29–36PubMedGoogle Scholar
  16. 16.
    Dahlin DC, Coventry MB (1967) Osteosarcoma: A study of 600 cases. J Bone Joint Surg [Am] 49: 101–110Google Scholar
  17. 17.
    Friedman MA, Carter SX (1972) The therapy of osteogenic sarcoma: Current status and thoughts for the future. J surg Oncol 4 (5): 482–510PubMedCrossRefGoogle Scholar
  18. 18.
    Taylor WF, Ivins JC, Dahlin DC, Edmonson JH, Pritchard DJ (1978) Trends and variability in survival from osteosarcoma. Mayo Clin Proc 53: 695–700PubMedGoogle Scholar
  19. 19.
    Weiner M, Harris M, Lewis M, Jones R, Sherry H, Feurer E, Johnson T, Lahman E (1986) Neoadjuvant high dose methotrexate, cisplatin, and doxorubicin for the management of patients with nonmetastatic osteosarcoma. Cancer Treat Rep 70: 1431–1432PubMedGoogle Scholar
  20. 20.
    Baum E, Greenberg L, Gaynon P (1978) Use of cisplatinumdiammine dichloride (CPDD) in osteogenic sarcoma (OS) in children (abstract C-315). Proc AACRASCO 19: 335Google Scholar
  21. 21.
    Nitschke R, Starling KA, Vats T, Bryan H (1978) Cis-Diamminedichloroplatinum (NSC-119875) in childhood malignancies: A southwest oncology group study. Med Pediatr Oncol 4: 127–132PubMedCrossRefGoogle Scholar
  22. 22.
    Pratt C, Hayes F, Green A (1979) Phase II pharmacokinetic study of cis-platinum diamminedichloride (CPDD) in children with solid tumors. Proc AACR-ASCO 20: 361Google Scholar
  23. 23.
    Baram TZ, van Tassel P, Jaffe NA (1988) Brain metastasis in osteosarcoma: Incidence, clinical and neurological findings and management options. J Neurooncol 6: 47–52PubMedCrossRefGoogle Scholar
  24. 24.
    Giuliano A, Feig S, Eilber F (1984) Changing metastatic patterns of osteosarcoma. Cancer 54: 2160–2164PubMedCrossRefGoogle Scholar
  25. 25.
    McCarten KM, Jaffe N, Kirkpatrick JA (1980) The changing radiographic appearance of osteogenic sarcoma. Ann Radiol 23: 203–208PubMedGoogle Scholar
  26. 26.
    Takaue Y, Slopis JM, Anzai T, Robertson R, Jaffe N (1985) Successful treatment of pulmonary and abdominal metastatic osteosarcoma. Med Pediatr Oncol 13: 126128Google Scholar
  27. 27.
    Eckardt II, Eilber FR, Dorey FI, Mirra IM (1987) The UCLA experience in the management of stage IIB osteosarcoma: 1972–1983. In: Enneking WF (ed) Limb salvage in musculoskeletal oncology. Churchill Livingstone, New York, pp 314–326Google Scholar

Copyright information

© Springer Japan 1992

Authors and Affiliations

  • Soo-Yong Lee
  • Chin Youb Chung
  • Goo Hyun Baek
  • Hong Sik Byun
    • 1
  1. 1.Department of Orthopedic SurgeryKorea Cancer Center HospitalSeoulKorea

Personalised recommendations